Document Detail


Expression of the human soluble epoxide hydrolase in Escherichia coli by auto-induction for the study of high-throughput inhibition assays.
MedLine Citation:
PMID:  19782755     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Soluble epoxide hydrolase (sEH) is a key enzyme involved in the metabolism of epoxy fatty acid mediators such as epoxyeicosatrienoic acids with emerging roles in the regulations of hypertension and inflammation. Inhibitors of human sEH (hsEH) are effective drug candidates for the treatment of cardiovascular diseases. Preparation of hsEH for enzyme inhibition studies has been carried out by using baculovirus expression system. We herein explored the feasibility of expression of hsEH in Escherichia coli cells for the study of high-throughput screening assays of enzyme inhibitors, because the bacterial expression system is easier to handle and more cost-effective than the baculovirus expression system. The functional target enzyme was successfully produced in prokaryotic expression system by an auto-induction method and exhibited comparable enzyme activity to that yielded in baculovirus expression system. The bacterial-hsEH showed similar sensitivity to the baculovirus-hsEH against six reported inhibitors. Overalls indicate that bacterial expression of hsEH employed in the present study is useful for preparing enzymatically active hsEH, leading to effective performance of high-throughput screening assay of hsEH inhibitors and to rapid identification of novel drug candidates for the treatment of cardiovascular diseases.
Authors:
Kosuke Nishi; In-Hae Kim; Seung-Jin Ma
Related Documents :
11513745 - Biochemical characterization of the beta-1,4-glucuronosyltransferase gelk in the gellan...
12135365 - Characterization of chimeric adpglucose pyrophosphorylases of escherichia coli and agro...
10215885 - Human high-km 5'-nucleotidase effects of overexpression of the cloned cdna in cultured ...
4970225 - New procedures for purification of l-asparaginase with high yield from escherichia coli.
6766135 - Inactivation of purified rat liver cytochrome p-450 during the metabolism of parathion ...
16678235 - Seasonal variability of oxidative biomarkers, lysosomal parameters, metallothioneins an...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-09-25
Journal Detail:
Title:  Protein expression and purification     Volume:  69     ISSN:  1096-0279     ISO Abbreviation:  Protein Expr. Purif.     Publication Date:  2010 Jan 
Date Detail:
Created Date:  2009-11-06     Completed Date:  2010-01-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9101496     Medline TA:  Protein Expr Purif     Country:  United States    
Other Details:
Languages:  eng     Pagination:  34-8     Citation Subset:  IM    
Affiliation:
Industry and Academic Cooperation Laboratory for Drug Development, Mokpo National University, Muan, Jeonnam 534-729, South Korea. kosuke.nishi@tecan.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cell Line
Electrophoresis, Polyacrylamide Gel
Enzyme Induction / drug effects
Enzyme Inhibitors / chemistry,  pharmacology
Epoxide Hydrolases / antagonists & inhibitors,  biosynthesis*,  isolation & purification
Escherichia coli / cytology,  drug effects,  metabolism*
High-Throughput Screening Assays / methods*
Humans
Immunoblotting
Inhibitory Concentration 50
Insects
Solubility / drug effects
Substrate Specificity / drug effects
Chemical
Reg. No./Substance:
0/Enzyme Inhibitors; EC 3.3.2.-/Epoxide Hydrolases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Large-scale expression in Escherichia coli and efficient purification of precursor and active caspas...
Next Document:  Bimodal modulation and continuous stimulation in optical imaging to map direction selectivity.